Free Media Partnership Between Medicina and the AD/PD™ 2026 Alzheimer’s Disease and Parkinson’s Disease Conference, 17–21 March 2026, Copenhagen, Denmark

The AD/PD™ Conference has become the leading event in the field of neurodegenerative diseases, attracting leading medical and scientific professionals from around the world. AD/PD™ now stands as an annual meeting, with a continuing focus on advances in research on and treatment of Alzheimer’s and Parkinson’s Diseases and related neurological disorders.

The forthcoming AD/PD™ 2026 meeting will take place as a hybrid conference in the wonderful city of Copenhagen, Denmark, and online. The continuing success of the AD/PD™ meetings is the result of several key aspects:

A high-quality scientific program covering the most recent research, developments, and treatments, with emphasis on overlaps and congruent results among AD, PD, and related neurological disorders. A multidisciplinary mix of participants representing both clinical investigators and basic scientists, in addition to both established investigators and young upcoming talents. An International Scientific Advisory Board covering a broad range of expertise in AD, PD, and related neurological disorders.

An attempt to provide an environment at the conference that encourages interaction, exchange of ideas, and networking opportunities among all participants. Junior Faculty Awards are intended to encourage attendance by young scientists at the Conference.

AD/PD™ remains unique in its academic quality, combined with an interactive and collegial environment. We believe that there is no other conference in the world that offers scientific content of this rigor in a condensed manner while concurrently providing an exceptionally comfortable and enjoyable environment. We invite you to join us at the AD/PD™ 2026 International Conference on AD and PD, and we hope to welcome you in spring 2026, either in Copenhagen or online.